Muhammad Riaz

Ball milling markedly boosts the dye adsorption performance of waste orange peel powder, enabling enhanced removal of methylene blue and methyl violet from water.

Nanotechnology has received a lot of attention from the scientific community because of the greater surface-to-volume ratio of nanomaterials, which phenomenally increases their efficacy in practical applications. Among the various synthesis techniques, the biogenic or green synthesis of nanomaterials shows advantages over other techniques such as physical, chemical, etc. This study reports the biogenic synthesis of silver nanoparticles (AgNPs) using aqueous bark extract of Aesculus indica. The as-synthesized NPs were characterized by UV–visible, FT-IR, XRD, and SEM, and then tested for their antioxidant and antimicrobial potency. We have identified phenols, flavonoids, tannins, saponins, and carbohydrates in the bark extract of A. indica. The extract-loaded-AgNPs showed the highest inhibition for Staphylococcus aureus (28.0 mm), Pseudomonas aeruginosa (17.66 mm), Escherichia coli (14.33 mm), Acetobacter serratia (14.00 mm), and Klebsiella pneumoniae (12.33 mm). The methanolic bark extract inhibited S. aureus (24.33 mm), P. aeruginosa (10.66 mm), E. coli (11.33 mm), A. serratia (9.66 mm), and K. pneumoniae (11.66 mm). Aqueous bark extract inhibited S. aureus (22.33 mm), P. aeruginosa (8.33 mm), E. coli (9.33 mm), A. serratiaa (8.33 mm), and K. pneumoniae (9.66 mm). Its aqueous extract showed the highest antioxidant potency; IC₅₀ (0.175 µg/mL) followed by the methanolic extract; IC₅₀ (0.210 µg/mL) and extract-loaded nanoparticles; IC₅₀ (0.901 µg/mL). Our findings provide meaningful interest for antioxidant, anti-microbial applications of, and AgNPs synthesis by, aqueous bark extract of A. indica.

Nanotechnology has become a dire need of the current era and the green synthesis of nanoparticles offers several advantages over other methods. Nanobiotechnology is an emerging field that contributes to many domains of human life, such as the formulation of nanoscale drug systems or nanomedicine for the diagnosis and treatment of diseases. Medicinal plants are the main sources of lead compounds, drug candidates and drugs. This work reports the green synthesis of Ag nanoparticles (AgNPs) using the aqueous bark extract of Zanthozylum armatum, which was confirmed by a UV absorption at 457 nm. XRD analysis revealed an average size of 18.27 nm and SEM showed the particles’ spherical shape, with few irregularly shaped particles due to the aggregation of the AgNPs. FT-IR revealed the critical functional groups of phytochemicals which acted as reducing and stabilizing agents. The bark extract showed rich flavonoids (333 mg RE/g) and phenolic contents (82 mg GAE/g), which were plausibly responsible for its high antioxidant potency (IC₅₀ = 14.61 µg/mL). Extract-loaded AgNPs exhibited the highest but equal inhibition against E. coli and P. aeruginosa (Z.I. 11.0 mm), whereas methanolic bark extract inhibited to a lesser extent, but equally to both pathogens (Z.I. 6.0 mm). The aqueous bark extract inhibited P. aeruginosa (Z.I. 9.0 mm) and (Z.I. 6.0 mm) E. coli. These findings—especially the biosynthesis of spherical AgNPs of 18.27 nm—provide promise for further investigation and for the development of commercializable biomedical products.

Mycobacterium tuberculosis, the causative agent of tuberculosis, is one of the leading causes of human deaths due to a single infectious agent. M. tuberculosis infection of the host initiates a local inflammatory response, resulting in the production of a range of inflammatory factors at the site of infection. These inflammatory factors may come in direct contact with M. tuberculosis and immune cells to activate different signaling pathways. One such factor produced in excess during inflammation is a phospholipid compound, Platelet Activating Factor C-16 (PAF C-16). In this study, PAF C-16 was shown to have a direct inhibitory effect on the growth of Mycobacterium bovis BCG (M. bovis BCG) and Mycobacterium smegmatis (M. smegmatis) in a dose- and time-dependent manner. Use of a range of PAF C-16 structural analogs, including the precursor form Lyso-PAF, revealed that small modifications in the structure of PAF C-16 did not alter its mycobacterial growth inhibitory properties. Subsequent experiments suggested that the attachment of aliphatic carbon tail via ether bond to the glycerol backbone of PAF C-16 was likely to play a vital role in its growth inhibition ability against mycobacteria. Fluorescence microscopy and flow cytometry using Propidium iodide (PI) indicated that PAF C-16 treatment had a damaging effect on the cell membrane of M. bovis BCG and M. smegmatis. Furthermore, the growth inhibitory effect of PAF C-16 was partially mitigated by treatment with membrane-stabilizing agents, α-tocopherol and Tween-80, which further suggests that the growth inhibitory effect of PAF C-16 was mediated through bacterial cell membrane damage.